Esperion Therapeutics, Inc. ($ESPR)
Halladay Benjamin โ Chief Financial Officer
Shares
221,270
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 3, 2026
EPS:Est: 0.23
Mar 10, 2026
EPS:0.22 (est: 0.23)-5.5%
Revenue:$168.45M (est: $166.12M)+1.4%
Transaction Details
| Insider | Halladay Benjamin |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 13, 2026 |
| Expiration Date | Mar 13, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 16, 2026 |
| Shares Purchased | 221,270 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 221,270 |
| Derivative | Derivative |
| Accession Number | 0001628280-26-018186 |
| Document | View SEC Filing |